Human Serum Albumin ELISA Kit: Accurate Quantification for Biopharmaceutical and Clinical Research

Concept: Human Serum Albumin Structure and Biophysical Properties

Human serum albumin is the most abundant protein in human plasma, accounting for fifty to sixty percent of total plasma protein, and is synthesized in the liver before release into the circulation. The molecule is a single-chain polypeptide of 585 amino acids with a molecular weight of approximately 66.5 kDa. Its most distinctive structural feature is a heart-shaped three-dimensional conformation comprising three highly homologous domains, designated I, II, and III, each of which subdivides into A and B subdomains. X-ray crystallography and nuclear magnetic resonance studies reveal that the tertiary structure is stabilized primarily by seventeen disulfide bonds, which confer exceptional structural stability while preserving the conformational flexibility needed for diverse ligand binding. Multiple hydrophobic pockets and charged grooves determine the molecule's capacity to bind a wide range of endogenous and exogenous substances, forming the structural basis of its multifunctionality.

Gene Regulation and Circulating Behavior

The albumin gene resides on the long arm of human chromosome four at locus 4q13.3, and its expression is regulated by transcription factors including HNF1, C/EBP, and D-site binding protein. The mature molecule contains thirty-five cysteine residues, thirty-four of which form intramolecular disulfide bonds, leaving only Cys-34 free. This unpaired sulfhydryl group constitutes the principal pool of reducing equivalents in the circulation and participates in redox balance. Physically, the isoelectric point of human serum albumin falls between 4.7 and 4.9, so the protein carries a negative charge at physiological pH, explaining its anodal migration in electrophoretic analysis. The denaturation temperature reaches 62 to 65 degrees Celsius, and the structure remains stable across pH 3 to 10. Dynamic light scattering analysis indicates a hydrodynamic radius of approximately 3.5 nanometers in aqueous solution, with a rotational correlation time near 40 nanoseconds.

Physiological Functions and Ligand Binding

Human serum albumin plays an irreplaceable role in maintaining plasma colloid osmotic pressure, a function arising directly from its high plasma concentration of 35 to 50 g/L and its distinctive physicochemical properties. Because albumin accounts for fifty to sixty percent of total plasma protein at a comparatively small molecular size, it contributes seventy-five to eighty percent of plasma colloid osmotic pressure, approximately 25 mmHg. Clinically, when serum albumin falls below 20 g/L, intravascular water shifts substantially into the interstitial space, producing edema and reduced effective circulating volume. Starling force balance describes this phenomenon quantitatively, and the reflection coefficient for albumin approaches 1.0, indicating highly efficient water retention. At the microcirculatory level, albumin also protects the endothelial glycocalyx, preserving vascular barrier integrity.

As a multifunctional transport protein, human serum albumin carries non-esterified fatty acids with a capacity of six to seven long-chain fatty acids per molecule and association constants between 10⁶ and 10⁸ M⁻¹. This high-capacity, moderate-affinity profile buffers fluctuations in plasma fatty acid concentration. The protein additionally transports bilirubin through domain I, thyroid hormone through domain III, heme through domain I, and metal ions including calcium and copper. Drug binding follows a structured pattern in which acidic compounds such as warfarin and phenytoin bind primarily at site I in subdomain IIA, while neutral and basic compounds such as diazepam and propranolol prefer site II in subdomain IIIA. Binding generally prolongs drug half-life while reducing immediate biological activity, since only free drug exerts pharmacological effect. Recent proteomic work has even detected albumin association with extracellular microRNAs, suggesting a possible role in intercellular communication.

Post-Translational Modifications and Disease Association

Research into albumin post-translational modifications has opened new analytical directions. In diabetes, non-enzymatic glycation generates glycated albumin, which reflects glycemic control over the preceding two to three weeks and detects short-term fluctuations more sensitively than hemoglobin A1c. Ischemia-modified albumin results from structural change at the amino terminus under ischemia and reperfusion conditions, and has become an auxiliary indicator in acute coronary syndrome research. Oxidative stress produces sulfhydryl oxidation variants, including human nonmercaptalbumin 1 and 2, which correlate with progression of neurodegenerative conditions such as Alzheimer disease and Parkinson disease. Advanced mass spectrometry can now detect multiple covalent modifications on a single molecule, and in end-stage renal disease albumin simultaneously displays glycation, carboxymethylation, and oxidation. Beyond their role as biomarkers, certain modified forms participate directly in disease pathogenesis and represent candidate intervention targets.

Research Frontiers: Recombinant Albumin and Therapeutic Applications

Recombinant human serum albumin technology is reshaping production of this reagent class. Using yeast systems such as Pichia pastoris or plant cell expression platforms, recombinant methods generate product structurally and functionally equivalent to plasma-derived albumin while eliminating the risk of blood-borne pathogen transmission. Genetic optimization strategies, including codon preference adjustment and secretion signal optimization, have raised yields to 5 to 10 g/L of culture medium, approaching commercial feasibility. Modified variants have also been developed, such as selective PEGylation at the Cys-34 position to extend half-life or introduction of additional cysteine residues to enhance antioxidant capacity. In tissue engineering and regenerative medicine, albumin hydrogels support adhesion and proliferation of hepatocytes and mesenchymal stem cells, with mechanical properties tunable through crosslinking density, and albumin serves as a component of bioinks in three-dimensional bioprinting.

Quantification Methods and Kit Selection

Measurement of human serum albumin is among the most routine and informative determinations in biochemical research, and the choice of method should match the specimen type and accuracy requirement. Bromocresol green binding at pH 4.2 offers a broad linear range up to 60 g/L with intraday coefficients of variation below three percent, while bromocresol purple reduces globulin interference and suits inflammatory study models. Chromatographic and mass spectrometric approaches provide higher accuracy and can resolve differently modified forms. Immunoassay formats add specificity when the target must be distinguished from other plasma proteins. Investigators should also account for physiological variables, since posture at collection can shift values by 3 to 5 g/L and neonatal levels are lower, approaching adult values only by six months of age.

For convenient and reproducible quantification, ANT BIO PTE. LTD. provides Human Serum Albumin OneStep ELISA Kit (S0C3021) and Human Serum Albumin Competitive OneStep ELISA Kit (S0C3044). The sandwich format suits conventional quantitative determination across serum, plasma, and culture supernatant specimens, while the competitive configuration offers higher sensitivity for low-abundance or small-volume samples. Both kits employ a streamlined one-step protocol that shortens total assay time and reduces procedural error, supporting applications in recombinant protein process development, cell culture monitoring, and bioprocess quality control, with all uses restricted to basic research.

Related Products

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.